These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 30613961)
1. LncRNA ST3Gal6-AS1/ST3Gal6 axis mediates colorectal cancer progression by regulating α-2,3 sialylation via PI3K/Akt signaling. Hu J; Shan Y; Ma J; Pan Y; Zhou H; Jiang L; Jia L Int J Cancer; 2019 Jul; 145(2):450-460. PubMed ID: 30613961 [TBL] [Abstract][Full Text] [Related]
2. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling. Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921 [TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ABHD11-AS1 promotes colorectal cancer progression and invasion through targeting the integrin subunit alpha 5/focal adhesion kinase/phosphoinositide 3 kinase/Akt signaling pathway. Luo J; Jiang Y; Wu L; Zhuo D; Zhang S; Jiang X; Sun Y; Huang Y Aging (Albany NY); 2021 Aug; 13(16):20179-20191. PubMed ID: 34375304 [TBL] [Abstract][Full Text] [Related]
5. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway. Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562 [TBL] [Abstract][Full Text] [Related]
6. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
7. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. Li Y; Zeng C; Hu J; Pan Y; Shan Y; Liu B; Jia L J Hematol Oncol; 2018 Jul; 11(1):89. PubMed ID: 29970122 [TBL] [Abstract][Full Text] [Related]
9. Activating transcription factor 3-activated long noncoding RNA forkhead box P4-antisense RNA 1 aggravates colorectal cancer progression by regulating microRNA-423-5p/nucleus accumbens associated 1 axis. Cheng Z; Jiang S; Tao R; Ge H; Qin J Bioengineered; 2022 Feb; 13(2):2114-2129. PubMed ID: 35034547 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA TPT1-AS1 promotes the progression and metastasis of colorectal cancer by upregulating the TPT1-mediated FAK and JAK-STAT3 signalling pathways. Zhang L; Ye F; Zuo Z; Cao D; Peng Y; Li Z; Huang J; Duan L Aging (Albany NY); 2021 Jan; 13(3):3779-3797. PubMed ID: 33428595 [TBL] [Abstract][Full Text] [Related]
11. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Xu M; Xu X; Pan B; Chen X; Lin K; Zeng K; Liu X; Xu T; Sun L; Qin J; He B; Pan Y; Sun H; Wang S Mol Cancer; 2019 Sep; 18(1):135. PubMed ID: 31492160 [TBL] [Abstract][Full Text] [Related]
12. lncRNA ZNF667-AS1 (NR_036521.1) inhibits the progression of colorectal cancer via regulating ANK2/JAK2 expression. Zhuang L; Ding W; Ding W; Zhang Q; Xu X; Xi D J Cell Physiol; 2021 Mar; 236(3):2178-2193. PubMed ID: 32853419 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis. Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200 [TBL] [Abstract][Full Text] [Related]
15. Ethoxy-erianin phosphate inhibits angiogenesis in colorectal cancer by regulating the TMPO-AS1/miR-126-3p/PIK3R2 axis and inactivating the PI3k/AKT signaling pathway. Liu S; Teng F; Lu Y; Zhu Y; Liang X; Wu F; Liu J; Zhou W; Su C; Cao Y BMC Cancer; 2024 Oct; 24(1):1275. PubMed ID: 39402462 [TBL] [Abstract][Full Text] [Related]
16. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway. Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932 [TBL] [Abstract][Full Text] [Related]
17. Silencing of lncRNA EZR-AS1 inhibits proliferation, invasion, and migration of colorectal cancer cells through blocking transforming growth factor β signaling. Liu Z; Wang N; Wang F; Zhang S; Ding J Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693738 [TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway. Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164 [TBL] [Abstract][Full Text] [Related]
19. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression. Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821 [TBL] [Abstract][Full Text] [Related]
20. JMJD2C promotes colorectal cancer metastasis via regulating histone methylation of MALAT1 promoter and enhancing β-catenin signaling pathway. Wu X; Li R; Song Q; Zhang C; Jia R; Han Z; Zhou L; Sui H; Liu X; Zhu H; Yang L; Wang Y; Ji Q; Li Q J Exp Clin Cancer Res; 2019 Oct; 38(1):435. PubMed ID: 31665047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]